Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.680
+0.020 (1.20%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $191.34 million as of December 20, 2024. Its market cap has decreased by -19.13% in one year.
Market Cap
191.34M
Enterprise Value
-6.60M
1-Year Change
-19.13%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $191.34M, an increase of 51.74%. That is a compound annual growth rate of 3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 189.10M | -48.73% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 193.27M |
| Perspective Therapeutics | 191.95M |
| Amarin Corporation | 191.48M |
| Gossamer Bio | 190.55M |
| Molecular Partners AG | 190.02M |
| Compass Therapeutics | 188.50M |
| Stereotaxis | 188.10M |
| Cybin | 186.41M |